Margaret Ginoza

Margaret Ginoza

Auto-generated profile, based on publicly available information

Margaret Ginoza

University of Miami Miller School of Medicine, Miami, Florida 33136, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2017 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
LHLucia A. Hindorff
Lucia A. Hindorff
VBVence L. Bonham
Vence L. Bonham
LBLawrence C. Brody
Lawrence C. Brody
MGMargaret E. C. Ginoza
Margaret E. C. Ginoza
CHCarolyn M. Hutter
Carolyn M. Hutter
EGEric D. Green
Eric D. Green

10 September 2019 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Closed access
PDF file
MGMargaret E.C. Ginoza
Margaret E.C. Ginoza
RIRosario Isasi
Rosario Isasi
Preimplantation genetic testing (PGT) is a reproductive technology that, in the course of in vitro fertilization (IVF), allows prospective parents to select their future offspring based on genetic characteristics. PGT could be seen as an exercise of reproductive liberty, thus potentially raising significant socioethical and legal controversy. In this review, we examine—from a comparative perspective—variations in policy approaches to the regulation of PGT. We draw on a sample of 19 countries (Australia, Austria, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Italy, Japan, Mexico, Netherlands, Singapore, South Korea, Switzerland, United Kingdom, and the United States) to provide a global landscape of the spectrum of policy and legislative approaches (e.g., restrictive to permissive, public vs. private models). We also explore central socioethical and policy issues and contentious applications, including permissibility criteria (e.g., medical necessity), nonmedical sex selection, and reproductive tourism. Finally, we further outline genetic counseling requirements across policy approaches.

27 October 2021 in Drug and Alcohol Dependence
Verified
Journal Article
Open access
HTHansel E. Tookes
Hansel E. Tookes
TBTyler S. Bartholomew
Tyler S. Bartholomew
ESEdward Suarez
Edward Suarez
EEElisha Ekowo
Elisha Ekowo
MGMargaret Ginoza
Margaret Ginoza
LMLisa R. Metsch
Lisa R. Metsch
Persons who inject drugs (PWID) have been a marginalized and a stigmatized population since the beginning of the AIDS epidemic and have not experienced the same life-changing benefits of antiretroviral therapy as others. Tele-Harm Reduction (THR) is a telehealth-enhanced, harm reduction intervention, delivered within a trusted SSP venue. It aims to facilitate initiation of care and achieve rapid HIV viral suppression among PWID living with HIV. In this mixed-methods study, we employed the Practical, Robust, Implementation and Sustainability Model (PRISM) implementation science framework to identify multilevel barriers and facilitators to implementing the THR intervention. Focus groups (n=2, 16 participants), stakeholder interviews (n=7) and in-depth interviews were conducted with PWID living with HIV (n=25). In addition, to assess feasibility and acceptability, we pilot tested the THR intervention and reported viral suppression at 6 months. Focus groups and stakeholder interviews revealed system and organizational level barriers to implementation including requirements for identification and in person visits, waiting times, stigma, case management inexperience, multiple electronic health records, and billing. A potential facilitator was using telehealth for case management and initial provider visit. In the in depth interviews conducted with PWID living with HIV, participants expressed that the SSP creates a convenient, comfortable, confidential environment for delivering multiple, non-stigmatizing PWID-specific services. 35 PWID living with HIV were enrolled in the pilot study, 35 initiated antiretroviral therapy, and 25 (78.1%) were virally suppressed at six months. Rooted in harm reduction, the THR intervention shows promise in being an acceptable and feasible intervention that may facilitate engagement in HIV care and viral suppression among PWID.

5 January 2023 in Regenerative Medicine
Verified
Journal Article
Open access
MFMorris Fabbri
Morris Fabbri
MGMargaret Ginoza
Margaret Ginoza
LALars Assen
Lars Assen
KJKarin Jongsma
Karin Jongsma
RIRosario Isasi
Rosario Isasi
Researchers can now coax human pluripotent stem cells to imitate the structure and spontaneous self-organization of the developing human embryo. Although these stem cell-based embryo models present... Plain language summary Following scientific advances, researchers can induce stem cells to model the development of the human embryo with increasing accuracy. The International Society for Stem Cel... Tweetable abstract The International Society for Stem Cell Research Guidelines are the eminent global standard for ethical conduct in stem cell research. Although they complement national governanc... Graphical abstract

7 June 2022 in Regenerative Medicine
Verified
Journal Article
Open access
RIRosario Isasi
Rosario Isasi
MGMargaret Ginoza
Margaret Ginoza
KJKarin Jongsma
Karin Jongsma
LALars Assen
Lars Assen
MFMorris Fabbri
Morris Fabbri
MOMorris
Morris
The past decades witnessed the slow evolution of Europe's heterogeneous stem cell (SC) policy and substantial scientific advances in the field. Parallel to these developments, professional organiza... Plain language summary European countries have adopted different types of rules or policies, including laws and professional standards, to regulate stem cell research. These differences are because...

25 November 2021 in Reptiles & Amphibians
Verified
Journal Article
Open access
PDF file
EMEdward Metzger
Edward Metzger
MGMargaret Ginoza
Margaret Ginoza